Zobrazeno 1 - 10
of 118
pro vyhledávání: '"A Azizi Saraji"'
Autor:
Heidar Sharafi, Bita Behnava, Alireza Azizi-saraji, Ali Namvar, Ali Anvar, Shima Salimi, Seyed Moayed Alavian
Publikováno v:
Virology Journal, Vol 18, Iss 1, Pp 1-10 (2021)
Abstract Background Chronic hepatitis C (CHC) is one of the most important comorbidities in patients with hereditary bleeding disorders (HBD). The present study aimed at evaluating the effectiveness of direct-acting antiviral agent (DAA)-based interf
Externí odkaz:
https://doaj.org/article/d354a4999533472693e5bb9bf1247125
Autor:
Baghaipour, Mohammadreza, Salimi, Tahmineh, Bahoush, Gholamreza, Jazebi, Mohammad, Ala, Fereydoun, Azizi Saraji, Alireza, Dorgalaleh, Akbar, Moazezi Nekoei Asl, Seyedeh Somayeh, Mohamadamini, Mahboobe, Tabibian, Shadi *
Publikováno v:
In Transfusion and Apheresis Science December 2021 60(6)
Autor:
Elnaz Agi, Saber Asghari, Ali Namvar, Niloofar Khairkhah, Niloofar Naderi, Ali Anvar, Alireza Azizi Saraji, Azam Bolhassani
Publikováno v:
Journal of Medical Microbiology and Infectious Diseases, Vol 8, Iss 1, Pp 1-6 (2020)
Introduction: A new pathological form of HCV named as occult HCV infection (OCI) has been recently characterized by the presence of HCV RNA in liver biopsy and/or peripheral blood mononuclear cell specimens (PBMCs) and the absence of detectable circu
Externí odkaz:
https://doaj.org/article/3f3b5b4694a94104a200d4cd0cb55f99
Autor:
Sanaz Asiyabi, Seyed Mahdi Marashi, Rohollah Vahabpour, Ahmad Nejati, Alireza Azizi-Saraji, Aliyeh Sadat Mustafa, Asgar Baghernejad, zabihollah Shoja, Hassan Mansouritorghabeh
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 15, Iss 3 (2021)
Background: Hemophilia is a well-known bleeding disorder with worldwide distribution. Replacement therapy, using plasma-derived or recombinant coagulation factors, comprises a gold standard regimen for the treatment. Regardless of the advancements ma
Externí odkaz:
https://doaj.org/article/cf0f3d53a4674146a67e6fdd25a4bdaf
Publikováno v:
Vaccine Research, Vol 4, Iss 1, Pp 41-45 (2017)
Introduction: Due to the role of neutralizing antibodies which can prevent human cytomegalovirus (HCMV) infection, most of the efforts have been focused on designing vaccines capable of eliciting protective humoral immunity. The aim of this study was
Externí odkaz:
https://doaj.org/article/1e5135dcda1a441cb1bac4ca848a40ce
Autor:
Zabihollah Shoja, Alireza Azizi-Saraji, Sanaz Asiyabi, Hassan Mansouritorghabeh, Asgar Baghernejad, Ahmad Nejati, Rohollah Vahabpour, Aliyeh Sadat Mustafa, Seyed Mahdi Marashi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research
International Journal of Hematology-Oncology and Stem Cell Research, Vol 15, Iss 3 (2021)
International Journal of Hematology-Oncology and Stem Cell Research, Vol 15, Iss 3 (2021)
Background: Hemophilia is a well-known bleeding disorder with worldwide distribution. Replacement therapy, using plasma-derived or recombinant coagulation factors, comprises a gold standard regimen for the treatment. Regardless of the advancements ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2983a6336a1e1c316f56fcb1c981beaa
http://europepmc.org/articles/PMC8748245
http://europepmc.org/articles/PMC8748245
Autor:
Masoumeh Foumani, Leila Asadpour, Alireza Azizi Saraji, Ali Sharifat Salmani, MohammadReza Aghasadeghi
Publikováno v:
Journal of Ardabil University of Medical Sciences, Vol 12, Iss 3, Pp 276-291 (2012)
Adjuvants are chemicals, microbial components, or mammalian proteins that enhance the immune response to vaccine antigens. Reducing vaccine-related adverse effects and inducing specific types of immunity has led to the development of numerous new adj
Externí odkaz:
https://doaj.org/article/b2a0437a43ff4f08add203bf18ee412f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Masoumeh Keshavarz Norouzpour, Niloofar Naderi, Afsaneh Seyed Mikaeili, Alireza Azizi Saraji, Azam Bolhassani, Hossein Yousefi, Mohammad Jazebi, Seyedeh Somayeh Moazezi Nekooi Asl, Sahar Mollazadeh, Elnaz Agi, Ali Namvar
Publikováno v:
Pediatric Hematology and Oncology. 36:28-39
A major problem of hemophilia A (HA) treatment is the development of factor VIII (FVIII) inhibitor, which usually occurs shortly after initiating replacement therapy. Several studies showed the correlation between inhibitor development and polymorphi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0038f0ebeb9833bcd6c182140221f4ce
https://doi.org/10.1080/08880018.2019.1585503
https://doi.org/10.1080/08880018.2019.1585503
Autor:
Shadi Tabibian, Mahboobe Mohamadamini, Akbar Dorgalaleh, Gholam Reza Bahoush, Seyedeh Somayeh Moazezi Nekoei Asl, Mohammad Reza Baghaipour, Alireza Azizi Saraji, Tahmineh Salimi, F. Ala, Mohammad Jazebi
Publikováno v:
Transfusion and Apheresis Science. 60:103212
Background Prophylaxis the current standard care for patients with severe hemophilia should be planned to optimize the replacement therapy and minimize bleeding. We report our single-center experience of tailored prophylaxis in children affected by h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6247346aef95b9961e5269c9e9f6b998
https://doi.org/10.1016/j.transci.2021.103212
https://doi.org/10.1016/j.transci.2021.103212